A Safety and Tolerability Study of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD)
Study Identifier
M06-889
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Study Details
Medical Condition
Study Drug
Phase
Phase 2
Sex
Female & Male
Age
18 - 60 Years
Protocol Summary
The objective of this study is to evaluate the long-term safety and tolerability of ABT-089 in adults with ADHD.
Study Locations
Location
Status
Location
Site Reference ID/Investigator# 6109
Mesa, Arizona, United States, 85210
Status
Not applicable
Location
Site Reference ID/Investigator# 6765
Mesa, Arizona, United States, 85210
Status
Not applicable
Location
Site Reference ID/Investigator# 6100
Lafayette, California, United States, 94549
Status
Not applicable
Location
Site Reference ID/Investigator# 6107
San Diego, California, United States, 92103-8620
Status
Not applicable
Location
Site Reference ID/Investigator# 6112
Jacksonville, Florida, United States, 32216
Status
Not applicable
Location
Site Reference ID/Investigator# 6096
Maitland, Florida, United States, 32751
Status
Not applicable
Showing {first} - {last} of {total} Results